These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23733874)

  • 61. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
    Kozako T
    Yakugaku Zasshi; 2011; 131(7):1061-72. PubMed ID: 21720136
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patient-individualized CD8⁺ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
    Distler E; Albrecht J; Brunk A; Khan S; Schnürer E; Frey M; Mottok A; Jordán-Garrote AL; Brede C; Beilhack A; Mades A; Tomsitz D; Theobald M; Herr W; Hartwig UF
    Int J Cancer; 2016 Mar; 138(5):1256-68. PubMed ID: 26376181
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.
    Ando S; Hasegawa A; Murakami Y; Zeng N; Takatsuka N; Maeda Y; Masuda T; Suehiro Y; Kannagi M
    J Immunol; 2017 Feb; 198(3):1210-1219. PubMed ID: 28011931
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model.
    Nomura M; Ohashi T; Nishikawa K; Nishitsuji H; Kurihara K; Hasegawa A; Furuta RA; Fujisawa J; Tanaka Y; Hanabuchi S; Harashima N; Masuda T; Kannagi M
    J Virol; 2004 Apr; 78(8):3827-36. PubMed ID: 15047798
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia.
    O'Hear C; Heiber JF; Schubert I; Fey G; Geiger TL
    Haematologica; 2015 Mar; 100(3):336-44. PubMed ID: 25480499
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IL-15 deficient tax mice reveal a role for IL-1α in tumor immunity.
    Rauch DA; Harding JC; Ratner L
    PLoS One; 2014; 9(1):e85028. PubMed ID: 24416335
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.
    Zhang M; Mathews Griner LA; Ju W; Duveau DY; Guha R; Petrus MN; Wen B; Maeda M; Shinn P; Ferrer M; Conlon KD; Bamford RN; O'Shea JJ; Thomas CJ; Waldmann TA
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12480-5. PubMed ID: 26396258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Tax-targeted DC vaccine for ATL].
    Suehiro Y
    Nihon Rinsho; 2017 Feb; 75(2):295-300. PubMed ID: 30562867
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
    Betancourt D; Ramos JC; Barber GN
    J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells.
    Kunihiro M; Fujii H; Miyagi T; Takahashi Y; Tanaka R; Fukushima T; Ansari AA; Tanaka Y
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27409630
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent.
    Nakamura D; Yoshimitsu M; Kuroki A; Hachiman M; Kamada Y; Ezinne CC; Arai A; Inoue H; Hamada H; Hayashida M; Suzuki S; Fujino S; Arima N; Arima M; Tabuchi T; Okada S; Arima N
    Exp Hematol; 2015 Nov; 43(11):944-50. PubMed ID: 26169955
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inefficient Tax-Specific T-Cell Responses in Mice after Syngeneic Transplantation with tax-Transgenic Mouse-Derived Adult T-Cell Leukemia Cells.
    Nakamura-Hoshi M; Suzuki T; Ainai A; Hasegawa H; Ishii H; Matano T
    Jpn J Infect Dis; 2020 May; 73(3):221-225. PubMed ID: 32009059
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia.
    Tanaka H; Fujiwara H; Ochi F; Tanimoto K; Casey N; Okamoto S; Mineno J; Kuzushima K; Shiku H; Sugiyama T; Barrett AJ; Yasukawa M
    Clin Cancer Res; 2016 Sep; 22(17):4405-16. PubMed ID: 27091408
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients.
    Kusuda M; Nakasone H; Yoshimura K; Okada Y; Tamaki M; Matsuoka A; Ishikawa T; Meno T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Yoshino N; Misaki Y; Gomyo A; Tanihara A; Kimura SI; Kako S; Kanda Y
    Br J Haematol; 2023 Aug; 202(3):578-588. PubMed ID: 37317804
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research.
    Tsukasaki K; Tobinai K
    Clin Cancer Res; 2014 Oct; 20(20):5217-25. PubMed ID: 25320371
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Application of HTLV-1 tax transgenic mice for therapeutic intervention.
    Hasegawa H; Sano K; Ainai A; Suzuki T
    Adv Biol Regul; 2018 May; 68():10-12. PubMed ID: 29588208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety.
    Ochi T; Fujiwara H; Okamoto S; An J; Nagai K; Shirakata T; Mineno J; Kuzushima K; Shiku H; Yasukawa M
    Blood; 2011 Aug; 118(6):1495-503. PubMed ID: 21673345
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A vaccine against HTLV-1 HBZ makes sense.
    Mahieux R
    Blood; 2015 Aug; 126(9):1052-3. PubMed ID: 26316613
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma.
    Narita T; Ishida T; Ito A; Masaki A; Kinoshita S; Suzuki S; Takino H; Yoshida T; Ri M; Kusumoto S; Komatsu H; Imada K; Tanaka Y; Takaori-Kondo A; Inagaki H; Scholz A; Lienau P; Kuroda T; Ueda R; Iida S
    Blood; 2017 Aug; 130(9):1114-1124. PubMed ID: 28646117
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
    Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
    Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.